skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
NY-ESO-1/LAGE-1 Peptide Vaccine (Code C74066)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: NY-ESO-1/LAGE-1 Peptide Vaccine

Definition: A cancer vaccine containing HLA class I- and II-binding peptides derived from the NY-ESO-1/LAGE-1 cancer/testis antigen with potential immunostimulatory and antineoplastic activities. Upon administration, NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine may induce a cytotoxic immune response against tumor cells that over-express NY-ESO-1/LAGE-1. Rarely expressed by normal cells, the NY-ESO-1/LAGE-1 cancer/testis antigen has been shown to be preferentially expressed on the surface of some cancer cell types.

Display Name: NY-ESO-1/LAGE-1 Peptide Vaccine

Label: NY-ESO-1/LAGE-1 Peptide Vaccine

NCI Thesaurus Code: C74066 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL383945  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
NY-ESO-1/LAGE-1 HLA Class I/II Peptide Vaccine
NY-ESO-1/LAGE-1 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 583632
PDQ Open Trial Search ID 583632 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C74066
Contributing_Source CTRP
Legacy_Concept_Name NY-ESO-1_LAGE-1_Peptide_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom